RxDoctor Payments Data

Katie Grund, MD

Family Medicine · Tucson, AZNPI 1265743835

Payments from drug & device makers

$641in general payments, 2019–2025

Across 39 payments — averaging $16.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$163
  • GSK$100
  • Amgen$85
  • Pfizer$80
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$48
  • Johnson & Johnson$41
  • plus $124 from 6 others

What the payments were for

  • Food & beverage$641100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$641 in reported general payments places this provider in the 65th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$139,593
Medicare patients
279
Services billed
3,921

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin54$70,383
OzempicSemaglutide36$45,497
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$43,104
JanuviaSitagliptin Phosphate32$39,166
Janumet XrSitagliptin Phos/Metformin Hcl24$37,963
EliquisApixaban17$25,121
MounjaroTirzepatide21$22,522
XareltoRivaroxaban11$19,854
FarxigaDapagliflozin Propanediol22$19,721
WegovySemaglutide14$18,874
MyrbetriqMirabegron13$14,906
Tresiba Flextouch U-200Insulin Degludec13$14,279
Spiriva RespimatTiotropium Bromide13$9,826
SymbicortBudesonide/Formoterol Fumarate23$8,124
Gabapentin237$5,940

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet Xr, Belsomra$13$82,32168 claims
Boehringer IngelheimJardiance, Spiriva Respimat$23$80,20967 claims
GSKTrelegy Ellipta$100$43,10431 claims
PfizerEliquis, Premarin, Paxlovid$80$32,40864 claims
Johnson & JohnsonXarelto$41$19,85411 claims
Astellas Pharma US IncMyrbetriq$30$14,90613 claims
AbbVieSynthroid$163$5,44068 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,099 family medicine providers in Arizona.

Other family medicine in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →